Using Reverse Phase Protein Arrays to Understand the Basis for Sensitivity and Resistance to BRAF Inhibitors in Metastatic MelanomaFriday, 13 September 2013 at 14:15 Add to Calendar ▼2013-09-13 14:15:002013-09-13 15:15:00Europe/LondonUsing Reverse Phase Protein Arrays to Understand the Basis for Sensitivity and Resistance to BRAF Inhibitors in Metastatic Melanoma Microarray World Congress in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com We are using reverse phase protein arrays, in combination with high content microscopy, to characterize the response of genetically characterized melanoma cell lines to BRAF inhibitor treatment in order to identify signalling pathways mediating sensitivity and resistance to these drugs. |